
Is this your show? Claim this page
PodCred
The people behind this show
People get invited back because someone remembered they were great.
PodCred is the verified record of who made this show. A credit here means people who were there confirmed the work.
Hosts
Who is on this show?
Think of the guest you still think about. The producer who makes the host sound smart. The editor who saves every episode. If a name is missing here, that person is invisible everywhere.
Add a creditEpisodes
101 episodesStephan Jackman: CEO of Alzamend Neuro
Stephan Jackman, CEO of Alzamend Neuro, shares his insights about leadership in biopharma and how Alzamend is working to develop effective treatments for psychiatric disorders.
Ryan Beal: Co-Founder and CEO of Dyve Biosciences
Ryan Beal, CEO of Dyve Biosciences, shares his insights about leadership in biopharma and how Dyve is working to deliver targeted pH modulation to treat a range of immunologic and oncologic diseases.
Haseeb Ahmad - CEO of Purespring Therapeutics
Haseeb Ahmad, CEO of Purespring Therapeutics, shares his insights about leadership in biopharma and how Purespring is working to help patients with kidney diseases to live fuller, healthier lives.
Lance Baldo: CEO of Beacon Therapeutics
Lance Baldo, CEO of Beacon Therapeutics, shares his insights about leadership in biopharma and how Beacon is working to save and restore sight for people living with rare and prevalent ocular diseases.
Shaun Bagai: CEO of RenovoRX
Shaun Bagai, CEO of RenovoRX, shares his insights about leadership in biopharma and how RenovoRX is working to develop targeted oncology therapies and commercialize its FDA cleared drug delivery device.
Hyung Heon Kim: CEO of MetaVia
Hyung Heon Kim, CEO of MetaVia, shares his insights about leadership in biopharma and how MetaVia is working to transform cardiometabolic disease.
David Southwell: CEO of Volastra Therapeutics
David Southwell, CEO of Volastra Therapeutics, shares his insights about leadership in biopharma and how Volastra is working to discover and develop oncology therapeutics targeting chromosomal instability, a...
Stacy Lindborg: CEO of Imunon
Stacy Lindborg, CEO of Imunon, shares her insights about leadership in biopharma and how Imunon is working to develop medicines that harness the building blocks of life to work in harmony with the body's immune system.
Welcome to Season 8 of BioBoss
BioBoss podcast host John Simboli reflects on Seasons 1-6 and invites listeners to Season 7 starting in January 2026
Michael Cloonan: CEO of Sionna Therapeutics
Michael Cloonan, CEO of Sionna Therapeutics, shares his insights about leadership in biopharma and how Sionna is working to restore the cystic fibrosis transmembrane conductance regulator for people living with cystic...
Erik van den Berg: CEO of Memo Therapeutics
Erik van den Berg, CEO of Memo Therapeutics, shares his insights about leadership in biopharma and how Memo is working to develop antibodies to transform the lives of patients with viral infections and cancer.
Bruce Leuchter: CEO of Neurvati Neurosciences
Bruce Leuchter, CEO of Neurvati Neurosciences, shares his insights about leadership in biopharma and how Neurvati is working to advance drugs with the potential to improve the health and lives of people living with...
Todd Harris: CEO of Tyra Biosciences
Todd Harris, CEO of Tyra Biosciences, shares his insights about leadership in biopharma and how Tyra is working to develop precision medicines that target large fibroblast growth factor receptor biology.
Eduardo Bravo: CEO of Citryll
Eduardo Bravo, CEO of Citryll, shares his insights about leadership in biopharma and how Citryll is working to transform the approach to treating immune mediated inflammatory diseases.
Abbas Kazimi: CEO of Nimbus Therapeutics
Abbas Kazimi, CEO of Nimbus Therapeutics, shares his insights about leadership in biopharma and how Nimbus is working to design and develop small molecule medicines capable of improving patients' lives.
Derek Adams: CEO of Stellular Bio
Derek Adams, CEO of Stellular Bio, shares his insights about leadership in biopharma and how Stellular Bio is working to expand the reach of regenerative medicine.
Geoffrey Dow: CEO of 60 Degrees Pharmaceuticals
Geoffrey Dow, CEO of 60 Degrees Pharmaceuticals, shares his insights about leadership in biopharma and how 60 Degrees Pharmaceuticals is working to develop vital medicines to treat and prevent infectious diseases.
Jorge Santos da Silva: Co-Founder and CEO of MoonLake Immunotherapeutics
Jorge Santos da Silva, co-founder and CEO of MoonLake Immunotherapeutics, shares his insights about leadership in biopharma and how MoonLake Immunotherapeutics is working to develop life changing therapies for people...
Vlad Vitoc - Founder and CEO of MAIA Biotechnology
Vlad Vitoc, founder and CEO of MAIA Biotechnology, shares his insights with BioBoss host John Simboli about leadership in biopharma and how MAIA is working to develop and deliver innovative medicines to improve and...
What Leads the Leaders? Insights from BioBoss Season 1
“What leads a leader?” As you listen to clips from BioBoss podcasts, you may hear remarkably consistent ideas about leadership, as shared by BioBoss guests, who reflect on their younger years and how those experiences...
Welcome to Season 7 of BioBoss
BioBoss podcast host John Simboli reflects on Seasons 1-6 and invites listeners to Season 7 starting in January 2025
Sam Clark: Founder and CEO of Terran Biosciences
Sam Clark, founder and CEO of Terran Biosciences, shares his insights with BioBoss host John Simboli about leadership in biopharma and how Terran is working to develop therapeutics and technologies for patients with...
Iain Kilty: CEO of Sitryx
Iain Kilty, CEO of Sitryx, shares his insights about leadership in biopharma and how Sitryx is working to alter immune cell metabolism to resolve disease
Steve Uden: Co-Founder and CEO of Rallybio
Steve Uden, co-founder and CEO of RallyBio, shares his insights about leadership in biopharma and how Rallybio is working to to profoundly change the odds for patients living with rare diseases.
Karine Rossignol: Co-Founder and CEO of Smart Immune
Karine Rossignol, co-founder and CEO of Smart Immune, shares her insights with BioBoss host John Simboli about leadership in biopharma and how Smart Immune is working to harness a patient's own thymus to re-arm the...
Erik Buntinx: Founder and CEO of ANeuroTech
Erik Buntinx, founder and CEO of ANeuroTech, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how ANeurotech is working to develop effective treatments, with minimal or no...
Helen Torley: CEO of Halozyme Therapeutics
Helen Torley, CEO of Halozyme Therapeutics, shares her thoughts with BioBoss host John Simboli about leadership in biopharma and how Halozyme is working to reinvent the patient experience by easing the burden of...
James Graham: CEO of Recce Pharmaceuticals
James Graham, CEO of Recce Pharmaceuticals, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Recce is working to develop a new class of synthetic anti-infectives designed to...
Mike Gaffney: CEO of Cellphire Therapeutics
Mike Gaffney, CEO of Cellphire Therapeutics, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Cellphire is working to save lives by bringing novel hemostatic products to patients...
David Baram: Founder and CEO of EmendoBio
David Barmam, founder and CEO of Emendio Biotherapeutics, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Emendo is working to evolve traditional CRISPR tools and create new...
Welcome to Season 6 of BioBoss
BioBoss podcast host John Simboli reflects on Seasons 1-5 and invites listeners to Season 6 starting in January 2024
Anat Binur: Co-Founder and CEO of Ukko
Anat Binur, co-founder and CEO of Ukko, shares her thoughts with BioBoss host John Simboli about leadership in biopharma and how Ukko is working to improve the lives of people who suffer from food allergies.
Markku Jalkanen: Founder and CEO of Faron Pharmaceuticals
Markku Jalkanen, founder and CEO of Faron Pharmaceuticals, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Faron is working to develop new immunotherapies to address unmet...
Lisa Deschamps: CEO of AviadoBio
Lisa Deschamps, CEO of AviadoBio, shares her thoughts with BioBoss host John Simboli about leadership in biopharma and how AviadoBio is working to develop transformative medicines for patients living with debilitating...
Leonard Mazur: Founder and CEO of Citius Pharma
Leonard Mazur, founder and CEO of Citius Pharmaceuticals, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Citius is working to unlock the potential of first-in-class critical...
Dario Neri: Co-Founder and CEO of Philogen
Dario Neri, co-founder and CEO of Philogen, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Philogen is working to discover and develop targeted therapies to treat cancer and...
Naseem Amin: CEO of Orphalan
Naseem Amin, CEO of Orphalan, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Orphalan is working to transform rare disease treatment.
Hartmut Ehrlich: CEO of Abivax
Hartmut Ehrlich, CEO of Abivax, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Abivax is working to develop treatments modulating the body’s natural immune system to treat...
Ivo Timmermans: Co-Founder and CEO of Pleco Therapeutics
Ivo Timmermans, co-founder and CEO of Pleco Therapeutics, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Pleco is working to develop breakthrough therapies that change the...
Philipp Spycher: Co-Founder and CEO of Araris Biotech
Philipp Spycher, co-founder and CEO of Araris Biotech, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Araris is working to develop a linker technology for antibody-drug...
Patrick Arensdorf: Founder and CEO of Exai Bio
Pat Arensdorf, founder and CEO of Exai Bio, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Exai is working to develop a next-generation RNA-based platform to deliver actionable...
Josh Geballe: Managing Director of Yale Ventures
Josh Geballe, Managing Director of Yale Ventures, shares his thoughts with BioBoss host John Simboli about leadership and community building in biopharma. Yale Ventures is a new initiative created by Yale University to...
Welcome to Season 5 of BioBoss
BioBoss podcast host John Simboli reflects on the success of seasons 1, 2 ,3 and 4 and welcomes listeners to listen in on his conversations about leadership with biopharma founders and CEOs in BioBoss season 5. John is...
Luca Benatti: CEO of EryDel
Luca Benatti, CEO of EryDel, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how EryDel is working to develop specialized therapies for the treatment of rare diseases by using the...
Elisabet de los Pinos: Founder and CEO of Aura Biosciences
Elisabet de los Pinos, founder and CEO of Aura Biosciences, shares her thoughts with BioBoss host John Simboli about leadership in biopharma and how Aura is working to envision new ways to treat cancer.
Paul Radspinner: Founder and CEO of Flugen
Paul Radspinner, founder and CEO of Flugen, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Flugen is working to develop a more effective vaccine in the fight against influenza...
Jesús Martin-Garcia: CEO of GeNeuro
Jesús Martin-Garcia, CEO of GeNeuro, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Geneuro is working to develop treatments against neurological disorders and autoimmune...
Cliff Stocks: Founder and CEO of OncoResponse
Cliff Stocks, founder and CEO of OncoResponse speaks with BioBoss host John Simboli. Hear Cliff’s insights about leadership in biopharma and how OncoResponse is working to identify fully human monoclonal antibodies as...
Brian Finrow: Co-Founder and CEO of Lumen Bioscience
Brian Finrow, Co-founder and CEO of Lumen Bioscience, speaks with BioBoss host and biopharma branding veteran John Simboli. Hear Brian’s thoughts about leadership and how Lumen Biosciences is working to unlock the full...
Alex Blyth: Founder and CEO of LifT BioSciences
BioBoss host John Simboli speaks with Alex Blyth, founder and CEO of LifT BioSciences.
Andrew Hall: CEO of IMV Inc.
Hear Andrew speak with BioBoss host John Simboli about leadership in biopharma and how IMV is working on advancing a portfolio of therapies based on the Company’s immune-educating platform.
Kevin Lee: CEO of Bicycle Biotherapeutics
Kevin Lee, CEO of Bicycle Therapeutics, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Bicycle Therapeutics is working on developing a new class of medicines, called Bicycles,...
Reenie McCarthy: CEO of Stealth BioTherapeutics
BioBoss host John Simboli speaks with Reenie McCarthy, CEO of Stealth BioTherapeutics, headquartered in Needham, MA.. Hear Reenie's thoughts about leadership in biopharma and how Stealth Biotherapeutics is working on...
Yochi Slonim: Founder and CEO of Anima Biotech
BioBoss host John Simboli speaks with Yochi Slonim, founder and CEO of Anima Biotech, headquartered in Boston with R&D in Tel Aviv.. Hear Yochi's thoughts about leadership in biopharma and how Anima Biotech is working...
Clive Richardson: CEO of Akari Therapeutics
BioBoss host John Simboli speaks with Clive Richardson, CEO of Akari Therapeutics, headquartered in London with offices in New York. Hear Clive's thoughts about leadership in biopharma and how Akari Therapeutics is...
Welcome to Season 4 of BioBoss
BioBoss podcast host John Simboli reflects on the success of seasons 1, 2 and 3 and welcomes listeners to listen in on his conversations about leadership with biopharma founders and CEOs in BioBoss season 4.
Stefan König: CEO of George Medicines
BioBoss host John Simboli speaks with Stefan König, CEO of George Medicines, headquartered in London. Hear Stefan’s thoughts about leadership in biopharma and how George Medicines is working to extend and improve the...
Derek Maetzold: CEO of Castle Biosciences
Derek Maetzold, CEO of Castle Biosciences shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Castle is leveraging its expertise in cancer genomics and the use of artificial...
Bob Cobuzzi: CEO of Diffusion Pharmaceuticals
Bob Cobuzzi, Chief Executive Officer of Diffusion Pharmaceuticals,speaks with BioBoss John Simboli about leadership and how Diffusion Pharmaceuticals is working to develop novel therapies that enhance the body’s ability...
Panna Sharma: CEO of Lantern Therapeutics
Panna Sharma, CEO of Lantern Pharma, headquartered in Dallas, Texas, shares his thoughts with BioBoss host John Simboli about leadership and how Lantern is working at the intersection of artificial intelligence,...
Nandan Padukone: CEO of IM Therapeutics
Nandan Padukone, CEO of IM Therapeutics, headquartered in Woburn, Massachusetts, shares his thoughts with BioBoss host John Simboli about leadership and how IM Therapeutics is targeting the root cause of autoimmunity...
Matthew Gline: CEO of Roivant Sciences
"I think I've always found motivation from being able to take a highly technical topic and dig in. I'm never the person that knows most about the topic. But I strive to be like the person who knows third or fourth most...
Koen De Witte: Managing Director of ReMYND
Koen De Witte, managing director of reMYND NV, headquartered in Leuven, Belgium, shares his thoughts with BioBoss host John Simboli about leadership and how reMYND is advancing treatments for Alzheimer’s, diabetes and...
Lanny Sun: Co-founder of Silicon Therapeutics
Lanny Sun, co-founder of Silicon Therapeutics, recently acquired by Roivant Sciences. speaks with corporate branding veteran John Simboli about leadership in biopharma. Lanny also discusses how Silicon Therapeutics, now...
Joan Perelló: Co-Founder and CEO of Sanifit
Joan Perelló, co-founder and CEO of Sanifit, shares his thoughts with BioBoss host John Simboli about leadership and how Sanifit is pursuing the development of treatments for progressive vascular calcification disorders.
Saiid Zarrabian: CEO of Kintara Therapeutics
Saiid Zarrabian, President and CEO of Kintara Therapeutics, shares his thoughts with BioBoss host John Simboli about leadership and how Kintara is pursuing the development of new cancer therapies for patients with rare...
John Temperato: CEO of 9 Meters Biopharma
John Temperato, President and Chief Executive Officer of 9 Meters Biopharma, speaks with BioBoss host John Simboli about leadership in biopharma and how 9 Meters is advancing drug candidates for patients with rare and...
Shawn Singh: CEO of VistaGen Therapeutics
Shawn Singh, CEO of VistaGen, speaks with BioBoss host John Simboli about leadership and VistaGen's working to develop a new generation of medications for anxiety, depression and other central nervous system disorders.
Welcome to Season 3 of BioBoss
BioBoss podcast host John Simboli reflects on the success of seasons 1 and 2 and welcomes listeners to listen in on his conversations about leadership with biopharma founders and CEOs in BioBoss season 3.
Bobby Gaspar: CEO of Orchard Therapeutics
Bobby Gaspar, founder and CEO of Orchard Therapeutics, speaks with BioBoss host John Simboli about leadership and how Orchard Therapeutics is pursuing the opportunity to change medicine and change the lives of people...
Itamar Kandel: CEO of HeartVista
Itamar Kandel, CEO of HeartVista, speaks with BioBoss host John Simboli about leadership and how HeartVista leverages machine learning to simplify diagnostic imaging and help physicians more accurately diagnose...
Mark Altmeyer: Founder and CEO of Arvelle Therapeutics
Mark Altmeyer, founder and CEO of Arvelle Therapeutics, speaks with BioBoss host John Simboli. Hear Mark’s thoughts about leadership and how Arvelle is working to bring new solutions to people living with epilepsy and...
Jacob Becraft: Co-Founder and CEO of Strand Therapeutics
Jacob Becraft, co-founder & CEO of Strand Therapeutics shares his thoughts with BioBoss host John Simboli about leadership and how Strand is working in synthetic biology and messenger RNA to target root causes of...
Eran Eden: Co-Founder and CEO of MeMed
Eran Eden, co-founder and CEO of MeMed, shares his thoughts on leadership and how MeMed is working to translate signals from the immune system into diagnostic insights to treat infectious disease and inflammatory...
Nikolaj Sørensen: CEO of Orexo
Nikolaj Sørensen, CEO of Orexo Therapeutics, shares his thoughts with BioBoss host John Simboli about leadership and, digital and bio-therapeutics, how the coronavirus is changing the landscape around mental health,...
Per Hellsund: Co-Founder and CEO of Cybrexa
Per Hellsund, co-founder and CEO of Cybrexa Therapeutics, shares his thoughts with BioBoss host John Simboli about leadership, building a culture of transparency, and Cybrexa's advances in treating the cancer tumor...
Clive Morris: CEO of Inivata
CEO Clive Morris of Inivata, headquartered in Cambridge U.K., shares his thoughts with BioBoss host John Simboli about leadership in biotech and advances in non-invasive liquid biopsy to unlock genomic information and...
Samuel Murphy: Co-Founder of Salubris Biotherapeutics
Salubris Biotherapeutics Co-founder Samuel Murphy shares his thoughts about leadership in biopharma with BioBoss host John Simboli. Samuel also discusses Salubris Biotherapeutics advances in therapeutics for the...
Jason Meyenburg: CEO of Gemini Therapeutics
Gemini Therapeutics CEO Jason Meyenburg share his thoughts about leadership in biopharma with BioBoss host John Simboli. Jason also discusses Gemini Therapeutics pioneering approach to developing precision medicines by...
Constantine Theodoropulos: Founder and CEO of Go Therapeutics
I'm not afraid of the gray area or the darkness that surrounds a few inches in front of your face, which is really what this business is all about." - Constantine Theodorpulos, Founder and CEO of Go Therapeutics
Ankit Mahadevia: CEO of Spero Therapeutics
"I really rely on the expertise of the team and I value input. I also value contradiction." - Ankit Mahadevia, founder and CEO of Spero Therapeutics
Lewis Bender: Founder and CEO of Intensity Therapeutics
"It would have been a tremendous regret to have never tried - much worse than trying and failing. Much worse." - Lewis Bender, Founder and CEO of Intensity Therapeutics,
Michel Detheux: CEO of iTeos Therapeutics
"I will always ask myself, what can I do with my knowledge in science to be able to bridge that to patients?" - Michel Detheux, co-founder and CEO of iTeos Therapeutics
Nessan Bermingham: CEO of Triplet Therapeutics
"Be very fair. You don't know it all. And be willing to actually listen to people. And when you're wrong, tell people you're wrong." - Nessan Bermingham: Founder, President and CEO of Triplet Therapeutics
Antony Mattessich: CEO of Ocular Therapeutix
"If you're a CEO, and you're doing things that are repetitive, then you're probably not doing your job." - Antony Mattessich, CEO of Ocular Therapeutix
Welcome to Season 2 of BioBoss
BioBoss host John Simboli welcomes you to Season 2!
George Goldsmith: Co-Founder and CEO of Compass Pathways
"The most creative thing in the world for me is just how does an idea get transformed by the people who collect around it." - George Goldsmith, Co-Founder and CEO of Compass Pathways
Yuval Cohen: CEO of Corbus Pharmaceuticals
“It's Biology that I love the most. It has a beauty in it that's actually quite hard to capture in numbers." - Yuval Cohen, CEO of Corbus Pharmaceuticals
Sven Karlsson: Co-Founder of Platelet BioGenesis
"Originally, I really thought about hiring people to do a list of activities and now I try to really think about hiring people to develop that list of activities to solve a problem" - Sven Karlsson, Co-Founder of...
Liang Schweizer: Co-Founder, President and CEO of HiFiBiO
"You just be yourself. That's the most effective way to lead. And on top of it, as a leader, you have to have vision." - Liang Schweizer, Co-founder, President, and CEO of HiFiBiO
Posts
No posts yet. Posts BioBoss shares on PodSubs, and what it publishes on Substack, YouTube and its own site, will show here.

Subscribe
Be on the front line of the show
Everything BioBoss sends its own people, first. Resources, announcements, behind the scenes, events, and giveaways, straight from the host. No account needed.
- The resources the host shares with subscribers
- Announcements before anyone else hears
- Behind the scenes from the team
- Events, invitations, and giveaways
- Only what the host sends, nothing else
Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.
















